Waystar Appoints Aashima Gupta and Michael Roman to Board of Directors

New directors bring deep expertise in AI innovation, healthcare, and enterprise growth

LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the appointment of two accomplished leaders, Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman of the Board and Chief Executive Officer of 3M, to its Board of Directors.

“We’re honored to welcome Aashima and Mike to Waystar’s Board,” said Matt Hawkins, Chief Executive Officer at Waystar. “They bring distinguished experience and expertise at the intersection of innovation, healthcare, and enterprise leadership. Their perspectives and strategic acumen will help guide our continued growth and innovation as we advance our mission to simplify healthcare payments and continue delivering long-term value to our clients, shareholders, and team members.”

Ms. Gupta brings significant expertise in AI strategy and digital transformation to improve healthcare access and efficiency. At Google Cloud, she has spearheaded groundbreaking healthcare AI initiatives, leveraging cloud and data technologies to improve care access, efficiency, and outcomes at scale. She also serves on the boards of Neogen, Mölnlycke Health Care, and the HIMSS Global Health Advisory Board. Modern Healthcare named Ms. Gupta one of the Top 10 Executives to Watch in 2024.

Mr. Roman served at 3M for nearly 40 years, including as CEO, chairman, and executive chairman. He is recognized for his strategic leadership, operational excellence, and product innovation at a global technology company generating approximately $32 billion in annual revenue, a quarter of which came from its healthcare division. Mr. Roman currently serves on the board of Abbott Laboratories and the Board of Trustees for the University of Minnesota Foundation.

About Waystar
Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar’s enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Media Contact
Kristin Lee
kristin.lee@waystar.com

Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-appoints-aashima-gupta-and-michael-roman-to-board-of-directors-302482680.html

SOURCE Waystar

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

14 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

14 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

14 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

14 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

14 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

14 hours ago